ymabs.com - Multiplikator EV/Sales YMAB

Simbol resmi perusahaan Y-mAbs Therapeutics Inc (YMAB)

The EV/Sales ratio provided by the GURU.Markets platform demonstrates the market resilience of Y-mAbs Therapeutics (YMAB). The figure expresses the current value of the metric, confirming high margins driven by monopoly sales of the drug Danyelza. Its status as a scientific leader in immuno-oncology ensures the company maintains physician trust. The business is currently scaling its portfolio of targeted antibodies and expanding distribution across US hospitals.

Y-mAbs Therapeutics (YMAB) - Rasio nilai perusahaan marang pendapatan saka 04.07.2022 nganti 20.11.2026

Rincian metrik keuangan lan pasar Y-mAbs Therapeutics, Inc. (YMAB)

Pambiji fundamental perusahaan:Y-mAbs Therapeutics YMAB
Sampel barang ymabs.com

For Y-mAbs Therapeutics (YMAB), the EV/Sales multiple reflects the enterprise value relative to generated revenue. This ratio eliminates the impact of capital structure, allowing for an assessment of the actual asset value per unit of sales. The high margins of Danyelza within the narrow neuroblastoma niche make this metric sensitive to demand dynamics. A stable market moat protects the company from sharp valuation swings, while low indicator values may signal liquidity risks.

Analisis pesaing Y-mAbs Therapeutics

Rasio nilai perusahaan marang dodolan BeiGene Ltd (ONC)|Halozyme Corp (HALO) - Rasio nilai perusahaan marang pendapatan|Multiplikator nilai perusahaan marang pendapatan Revolution Medicines Inc (RVMD)|Rasio nilai perusahaan marang pendapatan Ascentage Pharma Group|Rasio nilai perusahaan marang pendapatan CGON (CG Oncology Corp)|Rasio nilai perusahaan marang pendapatan UroGen Pharma (URGN)|Multiplikator EV/Sales Bicara Therapeutics (BCAX)|Multiplikator EV/Sales PSNL (personalis.com)|Nilai bisnis marang pendapatan ERAS|DCTH: Nilai perusahaan marang pendapatan|Multiplikator nilai perusahaan marang pendapatan Aura Corp|CADL: Multiplikator EV/Sales|ARAY - Rasio total nilai perusahaan marang pendapatan|SLS (SELLAS Life Sciences Group, Inc.) - Multiplikator EV/Sales|ACTU: Nilai bisnis marang pendapatan|Rasio nilai perusahaan marang pendapatan citiusonc.com (CTOR)|Rasio total nilai perusahaan marang pendapatan TuHURA Biosciences|Rasio nilai perusahaan marang pendapatan Protara Therapeutics TARA|Fate Therapeutics (FATE) - Multiplikator nilai perusahaan marang pendapatan|WHWK - Rasio nilai perusahaan marang pendapatan|Multiplikator nilai perusahaan marang pendapatan TScan Therapeutics Inc|championsoncology.com (CSBR) - Rasio nilai perusahaan marang pendapatan|Rasio nilai perusahaan marang pendapatan XBIT|Nilai perusahaan marang pendapatan CVM|Rasio nilai perusahaan marang pendapatan OSTX (OS Therapies Incorporated)|Multiplikator EV/Sales RADX|ARTV: Nilai perusahaan marang volume dodolan|Multiplikator EV/Sales ANL (Adlai Nortye Ltd)|VERU - Nilai perusahaan marang pendapatan|tempesttx.com - Multiplikator EV/Sales|Nilai bisnis marang pendapatan XLO (xiliotx.com)|RENB: Multiplikator EV/Sales|Nilai perusahaan marang pendapatan Mural Oncology plc|Rasio nilai perusahaan marang pendapatan Kairos Pharma Inc|OKUR: Nilai bisnis marang pendapatan|Multiplikator EV/Sales GDTC|CRIS (Curis) - Nilai bisnis marang pendapatan|Rasio nilai perusahaan marang pendapatan apollomicsinc.com APLM|THAR: Rasio nilai perusahaan marang pendapatan|advanbiomed.com - Multiplikator EV/Sales|Nilai bisnis marang pendapatan GNPX (Genprex, Inc)|Calidi Biotherapeutics Inc. (CLDI) - Rasio nilai perusahaan marang pendapatan|Sunshine Biopharma Inc. (SBFM) - Multiplikator EV/Sales|XBIO (Xenetic Bio) - Multiplikator EV/Sales|Salarius Pharmaceuticals Inc (SLRX) - Rasio total nilai perusahaan marang pendapatan|Multiplikator EV/Sales PPBT|Multiplikator EV/Sales American Oncology Network Inc (AONC)|Multiplikator EV/Sales BGNE (BeiGene Ltd.)|Koefisien nilai perusahaan marang pendapatan CKPT (Checkpoint Therapeutics)|ELEV - Rasio nilai perusahaan marang pendapatan|ICAD (iCAD Inc.) - Rasio nilai perusahaan marang pendapatan|Ikena (IKNA) - Rasio nilai perusahaan marang pendapatan|Nilai perusahaan marang pendapatan Notable Labs, Ltd.|Rasio nilai perusahaan marang pendapatan viracta.com|MOR: Nilai bisnis marang pendapatan|Multiplikator EV/Sales NAYA|Ascentage Pharma - Rasio nilai perusahaan marang pendapatan